Instructions for Authors
Scope and Mission
Journal of Cancer Chemotherapy (jacc) is an international, peer-reviewed journal committed to the advancement of knowledge and research across a broad spectrum of Cancer Chemotherapy disciplines. The journal provides a platform for high-quality publications in the fields of Cancer chemotherapy, Oncology research, Cancer treatment, Chemotherapeutic agents, Anti-Cancer drugs, Cancer therapeutics, Chemotherapy innovations. jacc welcomes scientifically rigorous contributions that offer novel insights, foster interdisciplinary dialogue, and demonstrate clinical or theoretical relevance in advancing the Cancer Chemotherapy.
Manuscript Submission Process
Authors are invited to submit manuscripts via the official online submission portal or directly through email at support@globalmeetx.com. Upon receipt, the corresponding author will receive a unique manuscript identification number within three (3) business days for tracking and future correspondence.
Note: Authors bear full responsibility for the originality, authenticity, and ethical standards of their submissions.
Compliance with Public Access Policies
In compliance with the NIH Public Access Policy, jacc submits NIH-funded articles to PubMed and PubMed Central upon publication. This compliance extends to research funded by the UK Research Councils and the European Union, facilitating open accessibility and transparency in biomedical research dissemination.
Editorial and Peer Review Process
All manuscripts undergo a structured editorial assessment followed by rigorous double-blind peer review. The journal publishes a diverse range of article types, including original research, comprehensive reviews, instructive case reports, expert commentaries, and methodological innovations. Authors are encouraged to enhance their manuscripts with relevant figures, illustrations, and tabular data to improve interpretability.
Expedited Review Option (FEE-Based Service)
jacc offers an optional expedited review service for authors seeking swift decisions:
- Initial Editorial Feedback: Completed within 3 business days
- Peer Reviewer Feedback: Provided within 5 business days
- Editorial Decision Post-Review: within 2 business days
Submission Requirements and Formatting Guidelines
Required Documents:
- Title Page (DOC format): Title, full author names, institutional affiliations, and corresponding author contact details
- Main Manuscript (DOC): Include tables (under two pages each) placed at the end
- Figures: Submit high-resolution figures separately in JPG, PNG, PPT, or DOC/DOCX (minimum 300 dpi)
- Cover Letter (DOC): Summarize the manuscript's significance, relevance to jacc, and declare any conflicts of interest
- Suggested Reviewers: Provide full names and professional emails for two potential reviewers, free of conflicts of interest or recent collaborations
Disclosures and Acknowledgments
- Acknowledgments: Clearly state contributions by individuals not listed as authors; prior written consent must be obtained
- Funding Disclosure: Identify all funding agencies with complete names and grant identifiers, where applicable
- Conflict of Interest Statement: Disclose any financial, institutional, or personal relationships that could be perceived as influencing the research, or explicitly declare "None to report"
Figures, Tables, and Supplementary Materials
- Tables: Must be numbered consecutively (e.g., Table 1, Table 2), formatted using MS Word's built-in table function, and placed at the manuscript's end
- Figures: Submit as separate files with descriptive captions included within the manuscript text (not embedded in image files)
- Supplementary Material: May include extended datasets, appendices, or multimedia, submitted as a single consolidated PDF
Reference Style and Citations
- Use numbered in-text citations in square brackets: [1], [2], etc.
- List all authors if six or fewer; for more than six, list the first six followed by et al.
- Only include published or in-press works; unpublished data and personal communications are not permitted in the reference list
Editorial Assessment and Revision Process
All manuscripts submitted to the Journal of Cancer Chemotherapy (jacc) undergo an initial screening by the editorial team to assess their alignment with the journal's scope, quality standards and ethical compliance. Only those submissions that meet the preliminary criteria (approximately 70% of all manuscripts) are forwarded for external peer review.
Authors whose manuscripts require revision will receive a detailed decision letter outlining the reviewers' feedback. Revisions must be submitted within 7 days from the date of notification. Extensions may be granted under exceptional circumstances upon written request to the editorial office.
Failure to submit revisions within the stipulated time frame may result in the withdrawal of the manuscript from consideration.
Proofing and Final Publication
Once a manuscript is accepted, the corresponding author will receive galley proofs in PDF format via email for final review. Authors are expected to carefully check for typographical, formatting or factual errors. No major content changes including data or author list modifications will be permitted at this stage.
Hard copies of the published article are available upon request. Authors may contact the editorial office to arrange print copies for institutional or personal use.
Article Processing Charges (APCs) and Publication Policy
Publishing with Globalmeetx Journals means your work will reach a global audience without barriers. Our Gold Open Access model is supported by an Article Processing Charge (APC), applied only upon acceptance. This single, transparent fee is an investment in your work's future, covering everything needed to elevate your manuscript to a highly visible, professional publication.
Your APC ensures your research receives:- Expert Validation: A rigorous peer review process to uphold quality.
- Professional Polish: Expert formatting, typesetting, and XML conversion to ensure your article meets the highest publication standards.
- Unlimited Reach: Immediate open access with a CC-BY license to maximize readership and potential citations.
- Permanent Discoverability: Submission for indexing in key databases and secure long-term archiving.
| Word Count Range | APC (EUR) |
|---|---|
| 150-1500 | € 299 |
| 1000-3000 | € 499 |
| 2000-7000 | € 699 |
We are committed to inclusive publishing. Waivers are available for authors facing financial difficulties, and we offer discounts through our institutional partnerships.
To discuss waiver options or institutional discounts: Please contact us at: support@globalmeetx.com | finance@globalmeetx.com